Receiver operating characteristic plot analysis was used to assess the sensitivity and specificity of VWF and CD163 in thrombi from patients with AIS treated with RS implantation in relation to their prognosis at 90 days post-operatively. This evidence concerns the gene CD163 and androgen insensitivity syndrome.